This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020).
European Nuclear Medicine/Radiopharmaceuticals Market expected worth $1.62 Billion by 2020
MarketsandMarkets™ - May 18, 2017